image
Esperion Therapeutics, Inc. ESPR
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 2.12
0.952 %
$ 418 M
Market Cap
-3.16
P/E
CASH FLOW STATEMENT
-135 M OPERATING CASH FLOW
22.50%
Growth Rates
1Year 22.50%
3Years -16.73%
5Years 1.84%
7Years -16.07%
10Years -22.29%
42.5 M INVESTING CASH FLOW
424.43%
Growth Rates
1Year 424.43%
3Years 25.78%
5Years -21.26%
7Years 22.76%
10Years 14.94%
50.5 M FINANCING CASH FLOW
54.76%
Growth Rates
1Year 54.76%
3Years -36.99%
5Years 36.38%
7Years 65.75%
10Years -5.53%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Esperion Therapeutics, Inc.
image
Net Income -209 M
Depreciation & Amortization 164 K
Capital Expenditures 0
Stock-Based Compensation 12 M
Change in Working Capital 13.7 M
Others 98.1 M
Free Cash Flow -135 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2002 Dec-2001 Dec-2000 Dec-1999
OPERATING CASH FLOW
Net Income (209.2) (233.7) (269.1) (143.6) (97.2) (201.8) (167.0) (75.0) (49.8) (36.4) (26.1) (11.7) (10.8) (28.7) (24.9) (27.6) (10.7)
Depreciation & Amortization 0.2 0.5 0.6 0.5 0.3 0.3 0.3 0.3 0.2 0.2 70.6 K 0.1 0.2 (1.3) (2.0) (2.0) (0.7)
Deferred Income Tax 0 0 (2.6) 97 K (0.2) 0 0.3 1.0 0.7 0.2 2.5 52 K 0.1 0 0 0 0
Stock Based Compensation 12.0 15.2 24.3 28.4 25.9 24.0 18.6 16.0 12.7 3.7 1.2 79.9 K 78.5 K 0 0 0 0
Other Operating Activities 48.0 46.5 35.5 33.8 8.1 (0.2) 23 K 44 K 61 K 31 K 0.9 1.5 0.6 3.9 5.2 8.7 1.6
Change in Working Capital 13.7 (3.4) (52.5) (4.3) (7.3) 29.2 16.5 10.0 (2.1) 0.3 3.2 (0.8) 0.8 (0.5) (1.1) 3.0 1.9
Cash From Operations (135.5) (174.8) (263.8) (85.2) (70.3) (148.6) (131.3) (47.7) (38.2) (32.0) (18.1) (10.8) (9.1) (26.6) (22.8) (18.0) (7.9)
INVESTING CASH FLOW
Capital Expenditures 0 0 0 (13.4) (1.0) (0.2) 19 K 94 K (0.3) (0.9) 31.4 K 6.78 K 33.6 K (1.2) (2.0) (1.3) (1.6)
Other Items 42.5 8.1 (50.5) 34.7 65.2 140.6 (35.8) 10.2 (159.7) (35.7) (21.0) 5.1 K 0.5 (4.3) (0.1) (0.7) 0
Cash From Investing Activities 42.5 8.1 (50.5) 21.4 64.2 140.4 (35.9) 10.1 (160.1) (36.6) (21.0) 1.68 K 0.5 (5.5) (2.1) (2.0) (1.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 (55.0) 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 271.6 0 (1.0) (1.7) (1.6) (0.6) 4.8 0 15.4 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (6.4) (58.2) 49.5 (14.9) 136.2 11.7 1.2 45 K 1.2 92.3 89.0 10 6.7 1.4 25.0 84.1 2.8
Cash From Financing Activities 50.5 32.6 268.2 201.7 136.2 10.7 163.5 (1.6) 190.5 97.1 89.1 15.8 6.7 1.4 25.0 84.1 2.8
CHANGE IN CASH
Net Change In Cash (42.5) (134.1) (46.1) 137.9 130.1 2.5 (3.7) (39.2) (7.7) 28.5 50.0 4.9 (1.8) (29.8) 58 K 64.3 (6.6)
FREE CASH FLOW
Free Cash Flow (135.5) (174.8) (263.8) (98.5) (71.3) (148.8) (131.3) (47.8) (38.5) (32.9) (18.1) (10.8) (9.1) (27.7) (24.8) (19.3) (9.4)